Altimmune, Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Altimmune, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Altimmune, Inc. Depreciation for the quarter ending March 31, 2024 was $107K, a 14.4% decline year-over-year.
  • Altimmune, Inc. annual Depreciation for 2023 was $477K, a 3.25% decline from 2022.
  • Altimmune, Inc. annual Depreciation for 2022 was $493K, a 23.3% increase from 2021.
  • Altimmune, Inc. annual Depreciation for 2021 was $400K, a 33.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $477K -$16K -3.25% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $493K +$93K +23.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $400K +$100K +33.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $300K +$60.2K +25.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $240K +$21.1K +9.65% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $219K +$135K +161% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $83.8K +$20.7K +32.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $63.1K -$78.5K -55.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $142K -$8.35K -5.57% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-14
2014 $150K -$32.5K -17.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $182K -$121K -40% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 $304K -$157K -34.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $461K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.